← Back
Data updated: Mar 29, 2026
ABRAXIS PHARM
DermatologyOncologyCardiovascular
Pharma
ABRAXIS PHARM is a pharmaceutical company focused on Dermatology, Oncology, Cardiovascular.
1972
Since
64
Drugs
-
Trials
398
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
HEPARIN SODIUM 2026-02-20
Labeling
HEPARIN SODIUM 2026-02-20
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
CEFAZOLIN SODIUM 2026-02-13
Efficacy
FLUOROURACIL 2026-02-10
Labeling
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 36%
4 drugs
Oncology 18%
2 drugs
Cardiovascular 18%
2 drugs
Infectious Disease 18%
2 drugs
Respiratory 9%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
Novartis big-pharma
Oncology, Cardiovascular, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Cardiovascular, Oncology, Respiratory
Active (14)
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% ERYTHROMYCIN LACTOBIONATE CLINDAMYCIN PHOSPHATE ZINC SULFATE AMPHOTERICIN B NALOXONE HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER AMINOCAPROIC ACID BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER NITROGLYCERIN DEXAMETHASONE FLUOROURACIL METHOTREXATE SODIUM
Discontinued (49)
HEPARIN SODIUM METRONIDAZOLE CEFAZOLIN SODIUM SULFAMETHOXAZOLE AND TRIMETHOPRIM GLYCOPYRROLATE DIGOXIN HYDROCORTISONE SODIUM SUCCINATE CHLORPROMAZINE HYDROCHLORIDE FUROSEMIDE POTASSIUM CHLORIDE NALBUPHINE HYDROCHLORIDE HALOPERIDOL ISOPROTERENOL HYDROCHLORIDE LEUCOVORIN CALCIUM LIDOCAINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE METHYLPREDNISOLONE SODIUM SUCCINATE THIAMINE HYDROCHLORIDE CYANOCOBALAMIN PROCAINAMIDE HYDROCHLORIDE DIAZOXIDE CHROMIC CHLORIDE DOPAMINE HYDROCHLORIDE METARAMINOL BITARTRATE CUPRIC SULFATE AMINOPHYLLINE DROPERIDOL SODIUM NITROPRUSSIDE VINBLASTINE SULFATE MANNITOL 25% BRETYLIUM TOSYLATE KANAMYCIN SULFATE DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE NANDROLONE DECANOATE VINCRISTINE SULFATE DACARBAZINE HYDROXOCOBALAMIN METHYLDOPATE HYDROCHLORIDE PROCAINE HYDROCHLORIDE CALCIUM GLUCEPTATE RITODRINE HYDROCHLORIDE M.V.C. 9+3 MANGANESE SULFATE NALBUPHINE CEPHAPIRIN SODIUM SODIUM HEPARIN SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER METRONIDAZOLE HYDROCHLORIDE CEPHALOTHIN SODIUM
Company Info
- First Approval
- 1972-02-15
- Latest
- 2003-01-06
- Applications
- 113